研究業績集

Review

• Miyoshi E, Moriwaki K, Nakagawa T. (2008) Biological Function of Fucosylation in Cancer Biology. J. Biochem. 143(6), 725-729.
• Miyoshi E, Nakano M. (2008) Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 8(16), 3257-3262.
• Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J, Taniguchi N. (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275 (9), 1939-48.
• Takahashi M, Yokoe S, Asahi M, Lee S, Li W, Osumi D, Miyoshi E, Taniguchi N. (2008) N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion. Biochimica et Biophysica Acta. 1780(3), 520-524.
• Zhao Y, Takahashi M, Gu J, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N. (2008) Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 99(7), 1304-1310.
• Moriwaki K, and Miyoshi E. (2010) Fucosylation and gastrointestinal cancer. World J Hepatology 2(4), 151-161.
• Miyoshi E, Ito Y, Miyoshi Y. (2010) Involvement of aberrant glycosylation in thyroid cancer. Journal of Oncology 2010:816595.
• Miyoshi E, Shinzaki S, Moriwaki K, Matsumoto H. (2010) Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for clinical use. Methods in Enzymology 478, 153-164.
• Moriwaki K and Miyoshi E. (2010) Roles of fucosylation in tumor immunology Trends in Glycoscience and Glycotechnology in press.
• Masuda T, Miyoshi E. (2011) Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.　Clin Chem Lab Med. 49(6), 959-66.
• Miyoshi E, Moriwaki K, Tearao N, Tang C C, Terao N, Nakagawa T, Matsumoto H, Shinzaki S, Kamada Y. (2012) Fucosylation is a promising target for cancer diagnosis and therapy. Biomolecule 2(1) 34-45.
• Nakayama K, Miyoshi E. Core fucose-specific lectin Pholiota terrestris lectin and its application to histochemistry. JCGGDB Glycoscience Protocol Online database 2012
• Ishii M, Shinzaki S, Miyoshi E. Induction of Colitis and its analysis. JCGGDB Glycoscience Protocol Online database 2013
• Miyoshi E, Terao M, Kamada Y. (2012) Physiological roles of N-acetylglucosaminyltransferase V (GnT-V) in mice. BMB report 45(10), 554-559.
• Tanemura M, Miyoshi E, Nagano H, Eguchi H, Taniyama K, Kamiike W, Mori M, Doki Y. (2013) Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer. Cancer Science 104(3), 282-290.
• Sawanobori A, Moriwaki K, Takamatsu S, Kamada Y, Miyoshi E, (2016) A glycoproteomic approach to identify novel glycomarkers for cancer stem cells. Proteomics 16 (24), 3073-80.
• Taniguchi N, Kizuka Y, Takamatsu S, Miyoshi E, Gao C, Suzuki K, Kitazume S, Ohtsubo K. (2016) Glyco-redox, a link between oxidative stress and changes of glycans: Lessons from research on glutathione, reactive oxygen and nitrogen species to glycobiology. Arch Biochem Biophys. 595, 72-80.
• Miyoshi E, Kamada Y (2016) Application of glyco-science to the early detection of pancreatic cancer. Cancer Science 107(10), 1357-1362.
• Shinzaki S, Iijima H, Fujii H, Kamada Y, Naka T, Takehara T, Miyoshi E.(2017) A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology. J. Biochem. 161(5), 409-415
• Kamada Y, Miyoshi E. (2017) Mac-2 binding protein is a useful liver fibrosis biomarker for NAFLD/NASH. Trends in Glycoscience and Glycotechnology 29 (170) E85-92. doi.10.4052/tigg.1714.1E.
• Miyoshi E , Kamada Y, Suzuki T. (2019) Functional glycomics: application to medical science and hepatology. Hepatology Research 50(2), 153-64.